Hanne Ostergaard, University of Alberta

Research

Adoptive Transfer Flow Cytometry Breast Cancer Cd8 T Cells Immune Response Inflammation Influenza Innate Lymphocytes

Latest papers

In Vitro Cytotoxicity and Cytokine Production by Lipid-Substituted Low Molecular Weight Branched PEIs Used for Gene Delivery.
Acta biomaterialia · 2022
Leupaxin Expression Is Dispensable for B Cell Immune Responses.
Frontiers in immunology · 2020

All 2 publications

Latest funding

Role of leupaxin in regulating the immune response to breast cancer
CIHR · 2024 · Nominated PI
$65,000
Precision Medicine for Autoinflammatory Disorders
SSHRC · 2023 · Co-investigator
$250,000
Priming Immune Cells for Genetic Modification
SSHRC · 2020 · Co-investigator
$250,000

All 7 grants and awards

2 publications.

01

In Vitro Cytotoxicity and Cytokine Production by Lipid-Substituted Low Molecular Weight Branched PEIs Used for Gene Delivery.

Meenakshi Sundaram DN, Plianwong S, Kc R, Ostergaard H, Uludağ H

Acta biomaterialia2022

DOI: 10.1016/j.actbio.2022.06.030 PMID: 35738388

02

Leupaxin Expression Is Dispensable for B Cell Immune Responses.

Bonaud A, Clare S, Bisio V, Sowerby JM, Yao S, Ostergaard H, Balabanian K, Smith KGC, Espéli M

Frontiers in immunology2020

DOI: 10.3389/fimmu.2020.00466 PMID: 32269569

Role of leupaxin in regulating the immune response to breast cancer

Nominated PICIHR2024CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer

Principal investigators: Ostergaard, Hanne L

Keywords: Breast Cancer

$65,000

Precision Medicine for Autoinflammatory Disorders

Co-investigatorSSHRC2023New Frontiers in Research Fund - Exploration

Principal investigators: Uludag, Hasan

Keywords: genetic and molecular therapy; autoimmunity; drug delivery; nucleic acids; RNAi; CRISPR; cytokine disorders

$250,000

Priming Immune Cells for Genetic Modification

Co-investigatorSSHRC2020New Frontiers in Research Fund - Exploration

Principal investigators: Uludag, Hasan

$250,000

Role of the cytoskeletal adaptor protein leupaxin in immune response regulation

Nominated PICIHR2019Project Grant - Priority Announcement: Infection and Immunity

Principal investigators: Ostergaard, Hanne L

Keywords: Adoptive Transfer; Cd8 T Cells; Flow Cytometry; Immune Response; Inflammation; Influenza; Innate Lymphocytes; Integrins; Leupaxin; Nk Cells

$100,000

Contribution of the cytoskeletal adaptor proteins paxillin and leupaxin to cytotoxic T cell migration and function

Nominated PICIHR2014Operating Grant

Principal investigators: Ostergaard, Hanne L

Keywords: Adaptor Proteins; Adoptive Transfer; Cell Adhesion; Cell Migration; Confocal Microscopy; Cytolytic Activity; Cytotoxic T Lymphocyte; Flow Cytometry; Lymphocyte Activation; T Cell Differentiation

$682,394

Intracellular trafficking of Fas ligand in cytotoxic T lymphocytes

Principal investigatorNSERC2013Discovery Grants Program - Individual

Principal investigators: Ostergaard, Hanne

$30,000

Symposium: Protective Antibodies Against Pathogens and Vaccines

Nominated PICIHR2010Planning Grants - Priority Announcement: Infection and Immunity

Principal investigators: Ostergaard, Hanne L

Keywords: Antibodies; Immunity; Infection; Inflammation; Vaccination

$10,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Adoptive Transfer Dear Professor Ostergaard, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "In Vitro Cytotoxicity and Cytokine Production by Lipid-Substituted Low Molecular Weight Branched PEIs Used for Gene Delivery." (2022), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Role of leupaxin in regulating the immune response to breast cancer" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]